Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Pregabalin NDC 68788-7522 by Preferred Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
pregabalin caps 75mg 30s count
The text represents information related to a medication called Pregabalin Capsules 75mg. The medication is a generic version of Lyrica and is produced by ScieGen Pharmceuticals Inc. Each capsule contains 75mg of pregabalin and is for oral use. The text also warns that Federal Law prohibits the transfer of this medication without a prescription.*
Figure 1 - pregabalin fig01
Figure 2 - pregabalin fig02
Figure 3 - pregabalin fig03
Figure 4 - pregabalin fig04
Figure 5 - pregabalin fig05
Figure 6 - pregabalin fig06
Figure 7 - pregabalin fig07
Figure 9 - pregabalin fig08
The text presents a graph showing the percentage of patients who improved in pain in relation to the daily doses of Pregabalin (300mg and 450mg) compared to Placebo. The x-axis shows the percentage of improvement from baseline and the y-axis shows the different treatments. However, there is no information on what condition or disease is being treated, making it difficult to provide more context other than showing the effectiveness of Pregabalin in improving pain.*
Figure 10 - pregabalin fig09
This appears to be a graph showing the estimated percentage of subjects without LTR (not sure what this stands for) over a period of 120 days. One line on the graph represents a group that received Progabain and the other line represents a placebo group. The x-axis shows the number of days from 0 to 120 with some numbers missing, and the y-axis shows the percentage from 0 to 100 with tick marks at every 10.*
Figure 11 - pregabalin fig10
Figure 12 - pregabalin fig11
Percent of subjects improved is being reported, with a specific percentage of improvement noted from Bassine to Week 16 being 80%. There is also a mention of "Presueuin Pcein". However, as the text is not clear and appears to be gibberish, the meaning or relevance of the mentioned term is not available.*
Cockcroft and Gault equation - pregabalin formula
This is a formula for estimating the creatinine clearance rate (CLCT) in patients. CLCT is calculated by subtracting the patient's age in years, multiplied by 140, from their weight in kilograms, and then multiplied by their serum creatinine level in mg/dL. For female patients, the result is multiplied by 0.85.*
Chemical Structure - pregabalin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.